GOLDMAN SACHS GROUP INC - VBI VACCINES INC ownership

VBI VACCINES INC's ticker is VBIV and the CUSIP is 91822J103. A total of 94 filers reported holding VBI VACCINES INC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VBI VACCINES INC
ValueSharesWeighting
Q1 2023$59,587
-15.1%
196,655
+9.6%
0.00%
Q4 2022$70,149
-67.1%
179,365
-40.6%
0.00%
Q3 2022$213,000
-78.2%
301,746
-75.1%
0.00%
Q2 2022$978,000
-41.3%
1,209,507
+20.5%
0.00%
Q1 2022$1,666,000
-38.3%
1,003,586
-13.0%
0.00%
-100.0%
Q4 2021$2,699,000
+158.8%
1,153,567
+243.9%
0.00%
Q3 2021$1,043,000
+54.1%
335,394
+65.9%
0.00%
Q2 2021$677,000
+31.2%
202,191
+21.9%
0.00%
Q1 2021$516,000
+35.4%
165,806
+19.7%
0.00%
Q4 2020$381,000
-59.4%
138,478
-57.8%
0.00%
Q3 2020$938,000
+287.6%
328,106
+320.6%
0.00%
Q2 2020$242,000
+59.2%
78,016
-51.5%
0.00%
Q1 2020$152,000
+10.9%
161,005
+61.9%
0.00%
Q4 2019$137,000
-78.7%
99,469
-81.9%
0.00%
Q2 2019$643,000
+536.6%
549,644
+1212.3%
0.00%
Q3 2018$101,000
-75.4%
41,884
-72.0%
0.00%
Q2 2018$411,000
+7.3%
149,380
+114.3%
0.00%
Q1 2017$383,00069,6960.00%
Other shareholders
VBI VACCINES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Perceptive Advisors 55,042,465$171,182,0002.49%
GENERAL AMERICAN INVESTORS CO INC 1,877,497$5,839,0000.50%
HighVista Strategies LLC 41,271$129,0000.08%
ArchPoint Investors 65,000$202,0000.06%
FIRST MIDWEST BANK TRUST DIVISION 136,714$425,0000.06%
FNY Investment Advisers, LLC 24,683$76,0000.04%
GRIMES & COMPANY, INC. 257,960$802,0000.04%
Cambridge Investment Research Advisors, Inc. 2,065,953$6,425,0000.03%
Ergoteles LLC 171,127$532,0000.02%
J.W. COLE ADVISORS, INC. 71,100$221,0000.02%
View complete list of VBI VACCINES INC shareholders